Trial Outcomes & Findings for Exercise and Cognitive Training in Parkinson's Disease (NCT NCT01156714)

NCT ID: NCT01156714

Last Updated: 2019-03-05

Results Overview

Dual task tested functional and cognitive performance while walking and talking simultaneously. Walking spatial and temporal parameters were measured using the Gaitrite 24 foot gaitmat with existing hardware and software for analysis. Cycle time refers to the amount of time taken for a participant to complete a single stride. Lower scores indicate better outcomes. The range of scores for Cycle Time is: Pre (0.73-2.47), Post (0.72-1.45).

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

59 participants

Primary outcome timeframe

baseline and 3 months

Results posted on

2019-03-05

Participant Flow

Participant milestones

Participant milestones
Measure
Arm 1: Treadmill Training
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Overall Study
STARTED
20
19
20
Overall Study
COMPLETED
11
15
17
Overall Study
NOT COMPLETED
9
4
3

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm 1: Treadmill Training
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Overall Study
Withdrawal by Subject
9
4
3

Baseline Characteristics

Exercise and Cognitive Training in Parkinson's Disease

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm 1: Treadmill Training
n=20 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=19 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=20 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Total
n=59 Participants
Total of all reporting groups
Age, Continuous
63.2 Years
STANDARD_DEVIATION 11.28 • n=5 Participants
73.68 Years
STANDARD_DEVIATION 8.38 • n=7 Participants
64.55 Years
STANDARD_DEVIATION 7.07 • n=5 Participants
67.00 Years
STANDARD_DEVIATION 9.36 • n=4 Participants
Sex: Female, Male
Female
6 Participants
n=5 Participants
5 Participants
n=7 Participants
4 Participants
n=5 Participants
15 Participants
n=4 Participants
Sex: Female, Male
Male
14 Participants
n=5 Participants
14 Participants
n=7 Participants
16 Participants
n=5 Participants
44 Participants
n=4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Asian
2 Participants
n=5 Participants
0 Participants
n=7 Participants
1 Participants
n=5 Participants
3 Participants
n=4 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Black or African American
3 Participants
n=5 Participants
5 Participants
n=7 Participants
1 Participants
n=5 Participants
9 Participants
n=4 Participants
Race (NIH/OMB)
White
15 Participants
n=5 Participants
14 Participants
n=7 Participants
18 Participants
n=5 Participants
47 Participants
n=4 Participants
Race (NIH/OMB)
More than one race
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants
n=5 Participants
0 Participants
n=7 Participants
0 Participants
n=5 Participants
0 Participants
n=4 Participants
Hoehn & Yahr Parkinson's Disease Severity Rating
2.34 units on a scale
STANDARD_DEVIATION .41 • n=5 Participants
2.42 units on a scale
STANDARD_DEVIATION .42 • n=7 Participants
2.35 units on a scale
STANDARD_DEVIATION .54 • n=5 Participants
2.42 units on a scale
STANDARD_DEVIATION .55 • n=4 Participants

PRIMARY outcome

Timeframe: baseline and 3 months

Population: \*\*Please note that initiation of dual-task testing was delayed by the original PI at the start of this study, such that some early participants were missed. This caused the dual-task outcome category to have lower numbers analyzed than other outcomes.

Dual task tested functional and cognitive performance while walking and talking simultaneously. Walking spatial and temporal parameters were measured using the Gaitrite 24 foot gaitmat with existing hardware and software for analysis. Cycle time refers to the amount of time taken for a participant to complete a single stride. Lower scores indicate better outcomes. The range of scores for Cycle Time is: Pre (0.73-2.47), Post (0.72-1.45).

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=8 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=13 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=15 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Dual Task Function #1
Cycle Time- baseline
1.15 seconds
Standard Error 0.152
1.12 seconds
Standard Error .04
.987 seconds
Standard Error .037
Dual Task Function #1
Cycle Time- 3 months
1.068 seconds
Standard Error .0375
1.09 seconds
Standard Error .052
.951 seconds
Standard Error .035

PRIMARY outcome

Timeframe: baseline and 3 months

Population: \*\*Please note that initiation of dual-task testing was delayed by the original PI at the start of this study, such that some early participants were missed. This caused the dual-task outcome category to have lower numbers analyzed than other outcomes.

Dual task tested functional and cognitive performance while walking and talking simultaneously. Walking spatial and temporal parameters were measured using the Gaitrite 24 foot gaitmat with existing hardware and software for analysis. Velocity was calculated by dividing the distance by the time it takes to travel that same distance, with consideration for direction. Higher values represent better outcomes. The range of scores for this study was: Pre (36.4 - 269.4), Post (76.3 - 267.6).

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=8 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=13 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=15 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Dual Task Function #2
Velocity- baseline
131.194 cm/sec
Standard Error 19.921
116.944 cm/sec
Standard Error 8.213
165.165 cm/sec
Standard Error 11.179
Dual Task Function #2
Velocity- 3 months
134.7 cm/sec
Standard Error 9.016
127.353 cm/sec
Standard Error 10.177
174.581 cm/sec
Standard Error 12.985

PRIMARY outcome

Timeframe: baseline and 3 months

2-Choice Reaction Time measures patients' ability to shift mental set. One of two stimuli are presented on the screen ("+ "or "\*"). Subjects press a specified response button on the keyboard corresponding to the presented stimulus. Units are "Throughput", which reflects efficiency of performance by being based on both accuracy and speed. Throughput represents correct responses/ minute.

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=11 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=15 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=17 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Cognitive Function #1
Two Choice Reaction- baseline
89.3535 correct responses/ minute
Standard Error 6.939
93.413 correct responses/ minute
Standard Error 6.227
101.236 correct responses/ minute
Standard Error 4.588
Cognitive Function #1
Two Choice Reaction- 3 months
105.677 correct responses/ minute
Standard Error 7.278
103.4767 correct responses/ minute
Standard Error 5.497
119.6465 correct responses/ minute
Standard Error 5.117

PRIMARY outcome

Timeframe: baseline and 3 months

The Stroop is a measure of selective attention and cognitive flexibility in which the subject must inhibit a preponderant response. Subjects are asked to complete three parts under timed conditions: (1) reading words describing colors written in black-and-white, (2) naming those colors when printed as X's, (3) naming the ink color when words describing the colors are mismatched with the colors (suppressing verbal content). Stroop interference scores from condition 3 are t-scores and higher scores equate with better outcomes.

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=11 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=15 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=17 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Cognitive Function #2
Stroop- baseline
48.37 t-score
Standard Error 1.278
41.74 t-score
Standard Error 2.581
48.4 t-score
Standard Error 1.54
Cognitive Function #2
Stroop- 3 months
48.9 t-score
Standard Error 1.642
47.8 t-score
Standard Error 2.522
47.941 t-score
Standard Error 1.93

PRIMARY outcome

Timeframe: baseline and 3 months

The Timed IADL involves the timing of performance of 5 tasks that mimic everyday instrumental activities of daily living: 1) finding a telephone number in the telephone directory, 2) counting out correct change from a group of coins, 3) finding then reading the ingredients on a food can label, 4) finding two food items in an array of food items (shopping), 5) finding then reading the directions on a medicine container. For each task there is a 2 minute time limit, with the exception of the telephone number task which has a limit of 3 mins. If the task is not completed within the time limit it is terminated. Error codes are assigned for each task. For the tasks completed with minor errors, a time penalty of 1 SD of those who completed the task is added to the completion time. Higher single item scores mean worse performance.The times for each of the tasks are transformed into Z scores which are then summed to form a composite score. Range for shopping item (0.61- 69.9 sec)

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=11 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=15 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=17 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Timed Instrumental Activities of Daily Living (TIADL) Function #1
Timed IADL's Composite- baseline
0.131 z-score
Standard Error 0.203
.234 z-score
Standard Error .164
-.2435 z-score
Standard Error 0.080
Timed Instrumental Activities of Daily Living (TIADL) Function #1
Timed IADL's Composite- 3 months
0.075 z-score
Standard Error .370
.1928 z-score
Standard Error .13866
-.34 z-score
Standard Error 0.065

PRIMARY outcome

Timeframe: baseline and 3 months

The Timed IADL for Shopping involved finding two food items in an array of food items. The task was timed in seconds and if completed with minor errors, a time penalty was added to the completion time. Higher scores/times meant worse performance. The range for shopping task completion was 0.61 to 69.9 seconds.

Outcome measures

Outcome measures
Measure
Arm 1: Treadmill Training
n=11 Participants
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=15 Participants
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=17 Participants
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Timed Instrumental Activities of Daily Living (TIADL) Function #2
TIADL Shopping- baseline
7.339 seconds
Standard Error 3.856
6.01 seconds
Standard Error 1.62
3.213 seconds
Standard Error 1.05
Timed Instrumental Activities of Daily Living (TIADL) Function #2
TIADL Shopping- 3 months
3.493 seconds
Standard Error 0.980
4.746 seconds
Standard Error 1.346
2.39 seconds
Standard Error 0.591

Adverse Events

Arm 1: Treadmill Training

Serious events: 0 serious events
Other events: 5 other events
Deaths: 0 deaths

Arm 2: Memory Training

Serious events: 0 serious events
Other events: 3 other events
Deaths: 0 deaths

Arm 3: Treadmill and Memory Training

Serious events: 1 serious events
Other events: 4 other events
Deaths: 0 deaths

Serious adverse events

Serious adverse events
Measure
Arm 1: Treadmill Training
n=20 participants at risk
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=19 participants at risk
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=20 participants at risk
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Cardiac disorders
Idiopathic orthostatic hypotension
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.0%
1/20 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.

Other adverse events

Other adverse events
Measure
Arm 1: Treadmill Training
n=20 participants at risk
Treadmill training with aerobic exercise treadmill training: walk on treadmill for aerobic exercise
Arm 2: Memory Training
n=19 participants at risk
Memory training with computerized memory program computerized memory training: memory testing and training on computer program
Arm 3: Treadmill and Memory Training
n=20 participants at risk
Combination of treadmill training and computerized memory program treadmill training: walk on treadmill for aerobic exercise computerized memory training: memory testing and training on computer program
Musculoskeletal and connective tissue disorders
fell at home
15.0%
3/20 • Number of events 5 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.3%
1/19 • Number of events 2 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
20.0%
4/20 • Number of events 11 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Skin and subcutaneous tissue disorders
Grover's disease
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.3%
1/19 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Musculoskeletal and connective tissue disorders
Fell outside at study site
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.3%
1/19 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
General disorders
migraine headache
5.0%
1/20 • Number of events 2 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.0%
1/20 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Skin and subcutaneous tissue disorders
mild skin irritation
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.0%
1/20 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Musculoskeletal and connective tissue disorders
muscular pain in arm
5.0%
1/20 • Number of events 3 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Musculoskeletal and connective tissue disorders
aggravated pre-existing back pain
5.0%
1/20 • Number of events 2 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
5.0%
1/20 • Number of events 1 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
Musculoskeletal and connective tissue disorders
dystonia
10.0%
2/20 • Number of events 2 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/19 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.
0.00%
0/20 • Adverse events were collected during a 5 month subject participation period which included 1 month of baseline testing, 3 months of intervention, and 1 month of post-testing.

Additional Information

Fred Ivey

VAORD

Phone: 410-605-7000

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place